Page last updated: 2024-10-17

aminocaproic acid and Obesity, Morbid

aminocaproic acid has been researched along with Obesity, Morbid in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenway, FL1
Liu, Z1
Yu, Y1
Caruso, MK1
Roberts, AT1
Lyons, J1
Schwimer, JE1
Gupta, AK1
Bellanger, DE1
Guillot, TS1
Woltering, EA1

Other Studies

1 other study available for aminocaproic acid and Obesity, Morbid

ArticleYear
An assay to measure angiogenesis in human fat tissue.
    Obesity surgery, 2007, Volume: 17, Issue:4

    Topics: Aminocaproic Acid; Angiogenesis Modulating Agents; Biological Assay; Fibrinogen; Humans; Neovascular

2007